<DOC>
	<DOCNO>NCT02903420</DOCNO>
	<brief_summary>A single arm , prospective , open , non-randomized , Japanese multicenter trial evaluate safety effectiveness Edwards SAPIEN 3 Transcatheter Heart Valve System ( Model : 9600TFX ) treatment symptomatic severe aortic stenosis patient chronic dialysis , determine heart team unable undergo safe open surgical therapy benefit study valve implantation .</brief_summary>
	<brief_title>A Clinical Trial Transcatheter Aortic Valves Dialysis Patients ( Japan )</brief_title>
	<detailed_description>1-year mortality study valve implantation compare performance goal base literature review clinical outcome dialysis patient underwent surgical aortic valve replacement . Data collect patient five year follow index valve replacement procedure .</detailed_description>
	<mesh_term>Constriction , Pathologic</mesh_term>
	<mesh_term>Aortic Valve Stenosis</mesh_term>
	<criteria>Patient determine heart team unable undergo open surgical therapy benefit study valve implantation . Patient senile degenerative aortic valve stenosis Patient dialysis ( hemodialysis peritoneal dialysis ) stable condition â‰¥ 3 month . Patient appropriate aortic valve annulus size measure TEE 3DCT . Patient evidence acute myocardial infarction ( MI ) within 30 day prior index procedure . Patient congenital unicuspid bicuspid aortic valve , noncalcified aortic valve . Patient severe aortic valve regurgitation . Patient severe mitral valve regurgitation . Patient experience therapeutic invasive cardiac procedure within 30 day prior index procedure . Implantation permanent pacemaker balloon valvuloplasty bridging procedure qualify echo consider exclusionary . Patient plan concomitant surgical transcatheter ablation atrial fibrillation .</criteria>
	<gender>All</gender>
	<minimum_age>19 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>February 2017</verification_date>
</DOC>